Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 132VERTEX PHARMS INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR

US Patent Number : 9012496

Drug Substance Claim :

Drug Product Claim :

Application Number : 212273

Patent Use Code : U-2649

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-07-15

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR

US Patent Number : 10022352

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212273

Patent Use Code : U-2651

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-04-09

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR

US Patent Number : 11639347

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 217660

Patent Use Code : U-3583

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-04-09

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR

US Patent Number : 11639347

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 217660

Patent Use Code : U-3583

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-04-09

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR

US Patent Number : 11578062

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 217660

Patent Use Code : U-3584

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-03-25

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR

US Patent Number : 11578062

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 217660

Patent Use Code : U-3584

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-03-25

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR

US Patent Number : 11564916

Drug Substance Claim :

Drug Product Claim :

Application Number : 217660

Patent Use Code : U-3585

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-08-13

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR

US Patent Number : 11564916

Drug Substance Claim :

Drug Product Claim :

Application Number : 217660

Patent Use Code : U-3585

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-08-13

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR

US Patent Number : 11517564

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 217660

Patent Use Code : U-3586

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-12-08

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR

US Patent Number : 11517564

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 217660

Patent Use Code : U-3586

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-12-08

blank